skip to content
Home

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 

News Subscribe to News

Read more at: IRC Investigator gives evidence at All Party Parliamentary Group on Brain Tumours

IRC Investigator gives evidence at All Party Parliamentary Group on Brain Tumours

24 March 2022

Dr Ruman Rahman, Associate Professor of Molecular Neuro-Oncology at the University of Nottingham, and IRC Investigator, contributed as a witness to the Oral Evidence Session for the All-Party Parliamentary Group on Brain Tumour (APPGBT) inquiry ‘Pathway to a Cure’ which was held virtually, Tuesday 22 March 2022. The panel...

Read more at: IRC Investigator to deliver Inaugural Professorial Lecture at Imperial College London

IRC Investigator to deliver Inaugural Professorial Lecture at Imperial College London

21 March 2022

Registration is now open for the IRC’s Professor Rylie Green’s Inaugural Professorial Lecture presenting the latest developments in polymer bioelectronics. The Inaugural Professorial Lecture, titled ‘Evolution of a cyborg: Bionic eyes, ears, spines and brains’ will consider the realisation of the cyborg – part human and...

Read more at: IRC Investigator co-writes academic textbook to shine a light on bionanotechnology

IRC Investigator co-writes academic textbook to shine a light on bionanotechnology

22 February 2022

The IRC’s Dr Ljiljana Fruk, Associate Professor in BioNano Engineering and Head of the BioNano Engineering Group at the University of Cambridge, is co-author of an academic textbook introducing the interdisciplinary and fast-developing field of bionanotechnology. Published by Cambridge University Press, the book titled ‘...

Read more at: Watch IRC panel discuss difficult cancers and a simulated operation on a model brain

Watch IRC panel discuss difficult cancers and a simulated operation on a model brain

18 February 2022

Four members of the IRC presented their work and research in a panel event that featured a simulated operation on a model brain to demonstrate the challenges faced by surgeons when attempting to fully remove glioblastoma . The recording of the event is now available to watch on the IRC YouTube channel. Hosted by the...

Read more at: Read first Cancer in Sight blog of 2022 – engaging a clinical line of sight to target pancreatic cancer’

Read first Cancer in Sight blog of 2022 – engaging a clinical line of sight to target pancreatic cancer’

27 January 2022

The first Cancer in Sight blog of the new year is by Prof Duncan Jodrell, Professor of Cancer Therapeutics at the University of Cambridge and one of the clinical leads for the IRC programme who explains the importance of a clearly defined clinical line of sight to the development of new therapeutics. The blog, titled ‘...

Read more at: IRC targeted drug delivery research highlighted by Department of Engineering

IRC targeted drug delivery research highlighted by Department of Engineering

11 January 2022

The collaborative and multidisciplinary work of the IRC features in the Department of Engineering’s latest news. The article titled ‘ How targeted drug delivery technologies can help in the fight against cancer ’ shines a light on IRC collaborations at the Department of Engineering at the University of Cambridge that...

Read more at: Read the end-of-year Cancer in Sight blog published today about one man’s exceptional experience of living with glioblastoma for 11 years

Read the end-of-year Cancer in Sight blog published today about one man’s exceptional experience of living with glioblastoma for 11 years

20 December 2021

This month’s extended IRC Cancer in Sight blog is written by Stephen Lee who has survived two brain surgeries and lived with glioblastoma since his diagnosis 11 years ago, age 51 – only four months after he lost his brother to the same disease. In the blog titled ‘ Looking to the future – while living with glioblastoma’...

Read more at: New animation explainer presents IRC’s approach to targeted drug delivery technologies for hard-to-treat cancers

New animation explainer presents IRC’s approach to targeted drug delivery technologies for hard-to-treat cancers

2 December 2021

The cross-disciplinary approach to develop targeted drug delivery technologies for three hard-to-treat cancers is explained in a new, short animation now available to view on the IRC website. The two-minute animation titled ‘ Why focus on drug delivery technologies in the fight against cancer? ’ presents the challenge...

Read more at: World Pancreatic Cancer Day

World Pancreatic Cancer Day

2 December 2021

Marking World Pancreatic Day on 18 November, the CRUK Cambridge Centre Pancreatic Cancer Programme hosted an expert panel event titled ‘Ask me anything about pancreatic cancer’. A podcast of the webinar is now available. Pancreatic cancer is one of three hard-to-treat cancers targeted by the IRC programme, along with...

Read more at: Read the latest Cancer in Sight blog published today

Read the latest Cancer in Sight blog published today

29 November 2021

This month’s IRC Cancer in Sight blog is written by Dr Ronan Daly, Associate Professor in Science and Technology of Manufacturing, based at the Institute for Manufacturing at the University of Cambridge, who leads this theme for the IRC programme. The blog, which is titled ‘Ahead of the game – the role of design for...

Contact Us

For more information on the EPSRC IRC in targeted delivery for hard-to-treat cancers, please contact the Programme Manager, Claire McGlynn

manager@targeted-delivery.cam.ac.uk

Study at Cambridge

About the University

Research at Cambridge